The case pertains to alleged corruption in the award of ₹2,200-crore civil works for Kiru hydropower project over Chenab ...

The apex court had directed the CBI to undertake a probe to unearth a possible nexus between builders and banks in ...

Longevity Health Holdings has secured a temporary reprieve from Nasdaq delisting, but the clock is ticking as the ...

The Central Bureau of Investigation (CBI) on Thursday filed a charge sheet against former Jammu and Kashmir Governor Satya ...

High-impact workshop on ‘Biotechnology Applications for Crop Improvement’ highlights genetically modified and gene-edited ...

From a struggling family tea estate to an innovative climate venture, Alt Carbon has raised $12 million in a seed round as it ...

Mamaearth parent Honasa Consumer, GMR Airports, Emcure Pharma among others will also announce their quarterly results on ...

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Bharat Biotech's Hillchol oral cholera vaccine completes phase III trials, proving non-inferiority and potential for global distribution.